The angiotensin II type 1 receptor antagonist olmesartan preserves cerebral blood flow and cerebrovascular reserve capacity, and accelerates rehabilitative outcomes in hypertensive patients with a history of stroke.

Source:http://linkedlifedata.com/resource/pubmed/id/20402577

Download in:

View as

General Info

PMID
20402577